1. What substances are NOT included in the definition of "Drug" under Schedule-I?
2. What is the purpose of the license to manufacture drugs for experimental purposes?
3. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
4. What is the main duty of a Federal Inspector?
5. What is the purpose of Schedule-III of the DRAP Act?
6. When can deviations be made from the information submitted during the registration of a drug?
7. What does the term "Advertise" mean under Schedule-II?
8. What type of containers are ophthalmic solutions and suspensions required to be contained in?
9. What is the fee for the renewal of registration of a new drug?
10. How many members does the Policy Board consist of?
11. What condition must be met for a drug or substance to be advertised through press without reference to the Federal Government?
12. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
13. Which term refers to the set of operations that establish the relationship between values indicated by an instrument and known reference standards?
14. What form should be used for applying for the grant or renewal of a licence to manufacture drugs?
15. What are the conditions that the Central Licensing Board must ensure are complied with before granting or renewing a licence to manufacture drugs by way of basic or semi-basic manufacture?
16. What is the primary focus of basic research in the context of the Drugs (Research) Rules?
17. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
18. Who is considered an "investigator" under the Drugs (Research) Rules?
19. In what circumstances shall a drug not be deemed misbranded or adulterated?
20. What is the meaning of "sponsor" in the context of the Drugs (Research) Rules?
21. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
22. Which of the following offenses punishable under Schedule-III is non-cognizable?
23. What is the purpose of the Central Research Fund mentioned in the Drugs Licensing, Registering & Advertising Rules 1976?
24. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
25. When a Federal Inspector is not competent to take action under Schedule-IV, what should he do?
26. The Drugs Act, 1976 extends to which of the following areas?
27. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
28. What is the commencement date for the Drugs (Specifications) Rules, 1978?
29. Which authority may authorize a Federal Inspector to disclose information acquired during official duties?
30. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
31. What are "Medical Devices" under Schedule-I?
32. What is the purpose of Form 6?
33. Who is responsible for carrying out the audit of the Authority's accounts?
34. What is the role of the Appellate Board under The Drug Regulatory Authority of Pakistan Act, 2012?
35. What is the definition of "Biological Drugs (Ready-to-fill form)" under Schedule-I?
36. What labeling requirements apply to drugs manufactured for experimental purposes?
37. How long do members, other than ex-officio members, of the Appellate Board hold office for initially?
38. Which of the following criteria should promotional claims about drugs adhere to?
39. What is the term of office for members of the Registration Board?
40. The Authority shall levy and collect fees for its functions at rates determined by:
41. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
42. What authority is responsible for inspecting and regulaying the manufacturing of drugs under 1976 rules?
43. What information should be included in the written contract between the contract giver and contract acceptor for contract manufacture?
44. In what situations can a drug or substance be advertised to the medical, pharmaceutical, and allied professions without referring to the Federal Government?
45. What action should the Authority take in response to objections raised by the Auditor-General?
46. What is the purpose of Form 10 in the export of drugs?
47. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
48. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
49. The Authority may open its accounts with:
50. When does an Inspector need to divide a sample into three portoons instead of four?
51. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
52. What stage of investigation on human beings involves determining safety, effectiveness, and common side effects of a drug?
53. What is the purpose of the criteria regarding medical representatives?
54. Who can revoke an order passed under Section 32 of the DRAP Act, 2012?
55. Which of the following is NOT considered as "Therapeutic goods" under the Act?
56. What is the short title of the rules that govern the Drugs Appellate Board?
57. What substances are NOT included in the definition of "Drug" under Schedule-I?
58. What is the definition of "promotion" for the purposes of Schedule G of 1976 Rules?
59. What are the types of licences to manufacture drugs under Drugs Licensing, Registering & Advertising rules 1976?
60. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
61. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
62. Who qualifies as a Federal Inspector according to these rules?
63. What is the purpose of a separate application for manufacturing drugs on more than one set of premises?
64. What is the maximum quantity of a single drug that can be imported for personal use without exceeding the limit?
65. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
66. What does an Inspector require from a person during a search or seizure under Schedule-V?
67. What is the role of the Quality Control Department in the manufacturing process?
68. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
69. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
70. According to the schedule in the Drugs (Specifications) Rules, what specifications should drugs bear that reference publications specified under sub-clause (ii) of clause (z) of Section 3?
71. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
72. How often must records of quarterly production and disposal of a drug be supplied to the Chairman of the Registration Board?
73. What kind of offense is non-cognizable under the Drugs Act 1976?
74. Who has the authority to establish the Drug Regulatory Authority of Pakistan?
75. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
76. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
77. According to the Drug Licensing, Registering & Advertisement rules 1976, what type of information should advertisements to physicians and health-related professionals be consistent with?
78. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
79. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
80. What are "Medical Devices" under Schedule-I?
81. Which of the following is NOT a source of financing the Drug Regulatory Authority Fund?
82. Within what time frame should the Authority submit its annual report to the Federal Government?
83. Which type of ophthalmic preparations is allowed to have a preservative?
84. What is the purpose of an "airlock" in pharmaceutical manufacturing?
85. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
86. What is the purpose of 'the Drugs (Federal Inspectors, Federal Drug Laboratory and Federal Government Analysts) Rules, 1976'?
87. What is the penalty for giving a false warranty in respect of any therapeutic good or applying a warranty given for another therapeutic good?
88. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
89. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
90. Which authority is responsible for issuing licences to manufacture drugs by way of repacking under section 18 of ordinance in a province?
91. What is the purpose of Schedule-III of the DRAP Act?
92. When does an Inspector need to divide a sample into three portoons instead of four?
93. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
94. What is the procedure for appealing the suspension or cancellation of a license under Drugs Import & Export Rules 1976?
95. Which of the following offenses punishable under Schedule-III is non-cognizable?
96. What is the fee for submitting an appeal to the Appellate Board, as mentioned in the rules?
97. What is the primary purpose of the Committee of Experts on Drug Research?
98. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
99. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
100. What is the purpose of the Drugs (Research) Rules, 1978?
